195 related articles for article (PubMed ID: 23894154)
21. TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
Cipollini M; Pastor S; Gemignani F; Castell J; Garritano S; Bonotti A; Biarnés J; Figlioli G; Romei C; Marcos R; Cristaudo A; Elisei R; Landi S; Velázquez A
Int J Cancer; 2013 Dec; 133(12):2843-51. PubMed ID: 23754668
[TBL] [Abstract][Full Text] [Related]
22. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.
Ho T; Zhao C; Zheng R; Liu Z; Wei Q; Sturgis EM
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):756-61. PubMed ID: 16847185
[TBL] [Abstract][Full Text] [Related]
23. Replication of genome-wide discovered breast cancer risk loci in the Cypriot population.
Loizidou MA; Hadjisavvas A; Ioannidis JP; Kyriacou K
Breast Cancer Res Treat; 2011 Jul; 128(1):267-72. PubMed ID: 21210208
[TBL] [Abstract][Full Text] [Related]
24. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma.
Chiang FY; Wu CW; Hsiao PJ; Kuo WR; Lee KW; Lin JC; Liao YC; Juo SH
Clin Cancer Res; 2008 Sep; 14(18):5919-24. PubMed ID: 18779313
[TBL] [Abstract][Full Text] [Related]
25. Common variants of the thyroglobulin gene are associated with differentiated thyroid cancer risk.
Akdi A; Pérez G; Pastor S; Castell J; Biarnés J; Marcos R; Velázquez A
Thyroid; 2011 May; 21(5):519-25. PubMed ID: 21476894
[TBL] [Abstract][Full Text] [Related]
26. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
Takahashi M; Saenko VA; Rogounovitch TI; Kawaguchi T; Drozd VM; Takigawa-Imamura H; Akulevich NM; Ratanajaraya C; Mitsutake N; Takamura N; Danilova LI; Lushchik ML; Demidchik YE; Heath S; Yamada R; Lathrop M; Matsuda F; Yamashita S
Hum Mol Genet; 2010 Jun; 19(12):2516-23. PubMed ID: 20350937
[TBL] [Abstract][Full Text] [Related]
27. Genome-Wide Association Study Reveals Distinct Genetic Susceptibility of Thyroid Nodules From Thyroid Cancer.
Hwangbo Y; Lee EK; Son HY; Im SW; Kwak SJ; Yoon JW; Kim MJ; Kim J; Choi HS; Ryu CH; Lee YJ; Kim JI; Cho NH; Park YJ
J Clin Endocrinol Metab; 2018 Dec; 103(12):4384-4394. PubMed ID: 30099483
[TBL] [Abstract][Full Text] [Related]
28. A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300.
Julià A; Domènech E; Ricart E; Tortosa R; García-Sánchez V; Gisbert JP; Nos Mateu P; Gutiérrez A; Gomollón F; Mendoza JL; Garcia-Planella E; Barreiro-de Acosta M; Muñoz F; Vera M; Saro C; Esteve M; Andreu M; Alonso A; López-Lasanta M; Codó L; Gelpí JL; García-Montero AC; Bertranpetit J; Absher D; Panés J; Marsal S
Gut; 2013 Oct; 62(10):1440-5. PubMed ID: 22936669
[TBL] [Abstract][Full Text] [Related]
29. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.
Tomaz RA; Sousa I; Silva JG; Santos C; Teixeira MR; Leite V; Cavaco BM
Clin Endocrinol (Oxf); 2012 Dec; 77(6):926-33. PubMed ID: 22882326
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.
Saad M; Lesage S; Saint-Pierre A; Corvol JC; Zelenika D; Lambert JC; Vidailhet M; Mellick GD; Lohmann E; Durif F; Pollak P; Damier P; Tison F; Silburn PA; Tzourio C; Forlani S; Loriot MA; Giroud M; Helmer C; Portet F; Amouyel P; Lathrop M; Elbaz A; Durr A; Martinez M; Brice A;
Hum Mol Genet; 2011 Feb; 20(3):615-27. PubMed ID: 21084426
[TBL] [Abstract][Full Text] [Related]
31. Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer.
Świerniak M; Wójcicka A; Czetwertyńska M; Długosińska J; Stachlewska E; Gierlikowski W; Kot A; Górnicka B; Koperski Ł; Bogdańska M; Wiechno W; Jażdżewski K
Clin Cancer Res; 2016 Mar; 22(5):1111-9. PubMed ID: 26490305
[TBL] [Abstract][Full Text] [Related]
32. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.
Festen EA; Stokkers PC; van Diemen CC; van Bodegraven AA; Boezen HM; Crusius BJ; Hommes DW; van der Woude CJ; Balschun T; Verspaget HW; Schreiber S; de Jong DJ; Franke A; Dijkstra G; Wijmenga C; Weersma RK
Am J Gastroenterol; 2010 Feb; 105(2):395-402. PubMed ID: 19861958
[TBL] [Abstract][Full Text] [Related]
33. Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis.
Ho T; Li G; Zhao C; Zheng R; Wei Q; Sturgis EM
Head Neck; 2008 Mar; 30(3):297-305. PubMed ID: 17657791
[TBL] [Abstract][Full Text] [Related]
34. RET polymorphisms and haplotypes and risk of differentiated thyroid cancer.
Ho T; Li G; Zhao C; Wei Q; Sturgis EM
Laryngoscope; 2005 Jun; 115(6):1035-41. PubMed ID: 15933516
[TBL] [Abstract][Full Text] [Related]
35. A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.
Kiyotani K; Mushiroda T; Tsunoda T; Morizono T; Hosono N; Kubo M; Tanigawara Y; Imamura CK; Flockhart DA; Aki F; Hirata K; Takatsuka Y; Okazaki M; Ohsumi S; Yamakawa T; Sasa M; Nakamura Y; Zembutsu H
Hum Mol Genet; 2012 Apr; 21(7):1665-72. PubMed ID: 22180457
[TBL] [Abstract][Full Text] [Related]
36. Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Masson G; He H; Jonasdottir A; Sigurdsson A; Stacey SN; Johannsdottir H; Helgadottir HT; Li W; Nagy R; Ringel MD; Kloos RT; de Visser MC; Plantinga TS; den Heijer M; Aguillo E; Panadero A; Prats E; Garcia-Castaño A; De Juan A; Rivera F; Walters GB; Bjarnason H; Tryggvadottir L; Eyjolfsson GI; Bjornsdottir US; Holm H; Olafsson I; Kristjansson K; Kristvinsson H; Magnusson OT; Thorleifsson G; Gulcher JR; Kong A; Kiemeney LA; Jonsson T; Hjartarson H; Mayordomo JI; Netea-Maier RT; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Genet; 2012 Jan; 44(3):319-22. PubMed ID: 22267200
[TBL] [Abstract][Full Text] [Related]
37. Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma.
Cancemi L; Romei C; Bertocchi S; Tarrini G; Spitaleri I; Cipollini M; Landi D; Garritano S; Pellegrini G; Cristaudo A; Pinchera A; Barale R; Elisei R; Landi S; Gemignani F
Int J Cancer; 2011 Dec; 129(12):2816-24. PubMed ID: 21520031
[TBL] [Abstract][Full Text] [Related]
38. The potential role of the sodium iodide symporter gene polymorphism in the development of differentiated thyroid cancer.
Al-Rasheed MM; Alzahrani AS; Macadam A; Overall A; Gard P; Dzimiri N
Gene; 2015 Nov; 572(2):163-8. PubMed ID: 26160439
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.
Cipollini M; Figlioli G; Maccari G; Garritano S; De Santi C; Melaiu O; Barone E; Bambi F; Ermini S; Pellegrini G; Cristaudo A; Foddis R; Bonotti A; Romei C; Vivaldi A; Agate L; Molinari E; Barale R; Forsti A; Hemminki K; Elisei R; Gemignani F; Landi S
DNA Repair (Amst); 2016 May; 41():27-31. PubMed ID: 27062014
[TBL] [Abstract][Full Text] [Related]
40. Role of DNA Repair Variants and Diagnostic Radiology Exams in Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.
Zidane M; Truong T; Lesueur F; Xhaard C; Cordina-Duverger E; Boland A; Blanché H; Ory C; Chevillard S; Deleuze JF; Souchard V; Ren Y; Zemmache MZ; Canale S; Borson-Chazot F; Schvartz C; Mariné Barjoan E; Guizard AV; Laurent-Puig P; Mulot C; Guibon J; Karimi M; Schlumberger M; Adjadj E; Rubino C; Guenel P; Cazier JB; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1208-1217. PubMed ID: 33827984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
